Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
Original Article
J.M. Connors, W. Jurczak, D.J. Straus, S.M. Ansell, W.S. Kim, A. Gallamini, A. Younes, S. Alekseev, Á. Illés, M. Picardi, E. Lech-Maranda, Y. Oki, T. Feldman, P. Smolewski, K.J. Savage, N.L. Bartlett, J. Walewski, R. Chen, R. Ramchandren, P.L. Zinzani, D. Cunningham, A. Rosta, N.C. Josephson, E. Song, J. Sachs, R. Liu, H.A. Jolin, D. Huebner, and J. Radford
N Engl J Med 2018;378:331-344
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.